WALTHAM, Mass.—BVI, an ophthalmic medical device maker based here, has completed its acquisition of Benz Research & Development and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Fla. The transaction terms were not disclosed. The Benz portfolio of performance materials in both intraocular lens (IOL) and contact lens manufacturing complements BVI's portfolio of IOLs under the PhysIOL brand, including the world's first trifocal lens, FineVision. The company is one of the few suppliers of raw materials for IOL production.

Read more